Synergy CHC (SNYR) EBITDA Margin (2014 - 2025)
Synergy CHC's (SNYR) quarterly EBITDA Margin came in at 219.45% in Q4 2025, down 1473.3% quarter-over-quarter from 15.98% in Q3 2025.
Synergy CHC (SNYR) EBITDA Margin (2014 - 2025) Analysis & Trends
Synergy CHC's EBITDA Margin history runs 10 years deep, the most recent figure standing at 219.45% for Q4 2025.
- On a quarterly basis, EBITDA Margin changed N/A year-over-year to 219.45% in Q4 2025; TTM through Dec 2025 was 29.89%, a 4264.0% decrease from a year earlier, with the FY2025 full-year figure at 27.84%, down 3071.0% from the prior year.
- EBITDA Margin fell to 219.45% in Q4 2025 per SNYR's latest filing, from 15.98% in the prior quarter.
- Across five years, EBITDA Margin topped out at 200.0% in Q1 2025 and bottomed at 219.45% in Q4 2025.
- The 3-year median for EBITDA Margin is 19.73% (2024), against an average of 31.56%.
- Across the five-year window, EBITDA Margin slumped 514 bps in 2024 and surged 18079 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 33.49% in 2023, then tumbled by 56 bps to 14.75% in 2024, then tumbled by 1588 bps to 219.45% in 2025.
- Per Business Quant, the three latest SNYR EBITDA Margin figures stand at 219.45% (Q4 2025), 15.98% (Q3 2025), and 180.42% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 2.23% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 1.63% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 0.84% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 5.40% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -0.01% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.73% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -41.35% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 6.59% |
| 10 | Synergy CHC | 1.63 Mn | -1.09 Mn | 2.22 Mn | -219.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -219.45% |
| Sep 30, 2025 | 15.98% |
| Jun 30, 2025 | 180.42% |
| Mar 31, 2025 | 200.00% |
| Sep 30, 2024 | 14.75% |
| Jun 30, 2024 | 19.73% |
| Mar 31, 2024 | 19.21% |
| Dec 31, 2023 | 33.49% |
| Sep 30, 2023 | 19.89% |
| Mar 31, 2020 | 16.43% |
| Dec 31, 2019 | -175.33% |
| Sep 30, 2019 | 4.93% |
| Jun 30, 2019 | 11.13% |
| Mar 31, 2019 | 19.26% |
| Dec 31, 2018 | -113.12% |
| Sep 30, 2018 | 6.96% |
| Jun 30, 2018 | -0.99% |
| Mar 31, 2018 | 4.39% |
| Dec 31, 2017 | -26.75% |
| Sep 30, 2017 | 4.85% |